Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Tapentadol in Major Urologic and Gynecologic Surgery
2012-004585-18Phase 3Completed
- Sponsor
- Philipps-Universität Marburg
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tapentadol in postoperative pain and postoperative nausea and vomiting (PONV), sponsored by Philipps-Universität Marburg. Primary endpoint: cumulative Simplified PONV Impact Scale Score AUC. Started Dec 2012; status: completed.
02
Drugs
tapentadol
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2012-004585-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004585-18.